Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 18 04:00PM ET
2.09
Dollar change
-0.12
Percentage change
-5.43
%
Index- P/E- EPS (ttm)-1.20 Insider Own10.09% Shs Outstand16.79M Perf Week-8.53%
Market Cap17.66M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float7.60M Perf Month-0.48%
Income-11.51M PEG- EPS next Q- Inst Own11.63% Short Float0.06% Perf Quarter-2.34%
Sales0.00M P/S- EPS this Y- Inst Trans68.04% Short Ratio0.14 Perf Half Y-2.79%
Book/sh3.68 P/B0.57 EPS next Y- ROA-1.53% Short Interest0.00M Perf Year-31.48%
Cash/sh7.24 P/C0.29 EPS next 5Y- ROE-1.81% 52W Range1.76 - 3.04 Perf YTD-3.24%
Dividend Est.- P/FCF- EPS past 5Y56.96% ROI-23.54% 52W High-31.14% Beta-0.17
Dividend TTM- Quick Ratio8.16 Sales past 5Y0.00% Gross Margin- 52W Low18.75% ATR (14)0.15
Dividend Ex-Date- Current Ratio8.16 EPS Y/Y TTM-8.69% Oper. Margin0.00% RSI (14)46.80 Volatility7.55% 7.73%
Employees2 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom- Target Price-
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-1524.38% Payout- Rel Volume0.24 Prev Close2.21
Sales Surprise- EPS Surprise-75.00% Sales Q/Q- Earnings- Avg Volume30.79K Price2.09
SMA20-0.82% SMA50-2.32% SMA200-4.49% Trades Volume7,352 Change-5.43%
May-21-24 09:00AM
Mar-19-24 06:53AM
Dec-18-23 11:51AM
Nov-15-23 08:30AM
07:30AM
09:15AM Loading…
Oct-31-23 09:15AM
Jun-15-23 09:15AM
May-11-23 08:30AM
Feb-02-23 09:00AM
Oct-07-22 09:00AM
Aug-15-22 08:30AM
Jul-28-22 12:49PM
09:00AM
Jul-21-22 08:30AM
Jul-19-22 08:30AM
08:30AM Loading…
Jul-11-22 08:30AM
06:00AM
Jul-05-22 03:16PM
08:30AM
Jun-23-22 09:00AM
Jun-15-22 08:30AM
Jun-13-22 08:30AM
Jun-09-22 09:00AM
Jun-08-22 08:30AM
Jun-02-22 09:00AM
May-23-22 09:00AM
May-11-22 09:00AM
Apr-27-22 09:00AM
Apr-19-22 09:00AM
Apr-13-22 09:00AM
09:00AM Loading…
Apr-05-22 09:00AM
Mar-22-22 09:00AM
Mar-16-22 09:00AM
Feb-22-22 09:00AM
Feb-14-22 09:00AM
Jan-06-22 09:00AM
Jan-04-22 09:00AM
Dec-28-21 09:00AM
Dec-15-21 09:00AM
Dec-08-21 10:16AM
Nov-30-21 01:05AM
Nov-12-21 09:00AM
Sep-27-21 09:00AM
Sep-21-21 09:00AM
Sep-16-21 09:00AM
Sep-08-21 09:00AM
Aug-31-21 09:20AM
Aug-25-21 09:00AM
Aug-23-21 04:39PM
Aug-19-21 07:19AM
Aug-16-21 09:00AM
Aug-12-21 03:00PM
Aug-09-21 05:37PM
Aug-02-21 04:58PM
Jul-14-21 08:45AM
Jul-13-21 07:57PM
Jul-09-21 07:11PM
Jul-08-21 09:00AM
Jun-24-21 09:00AM
Jun-22-21 09:00AM
Jun-18-21 09:00AM
Jun-14-21 09:00AM
Apr-01-21 09:00AM
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Las Vegas, NV.